Celemics Inc
Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It als… Read more
Celemics Inc (331920) - Total Assets
Latest total assets as of September 2025: ₩25.88 Billion KRW
Based on the latest financial reports, Celemics Inc (331920) holds total assets worth ₩25.88 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Celemics Inc - Total Assets Trend (2017–2024)
This chart illustrates how Celemics Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Celemics Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Celemics Inc's total assets of ₩25.88 Billion consist of 41.0% current assets and 59.0% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩3.96 Billion | 13.5% |
| Accounts Receivable | ₩543.33 Million | 1.9% |
| Inventory | ₩1.10 Billion | 3.7% |
| Property, Plant & Equipment | ₩1.80 Billion | 6.1% |
| Intangible Assets | ₩48.98 Million | 0.2% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Celemics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Celemics Inc's current assets represent 41.0% of total assets in 2024, a decrease from 43.3% in 2017.
- Cash Position: Cash and equivalents constituted 13.5% of total assets in 2024, down from 23.5% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2017.
- Asset Diversification: The largest asset category is cash and equivalents at 13.5% of total assets.
Celemics Inc Competitors by Total Assets
Key competitors of Celemics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Celemics Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Celemics Inc generates 0.23x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Celemics Inc generates $ 41.70 in net profit.
Celemics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.19 | 8.07 | 24.77 |
| Quick Ratio | 4.39 | 7.15 | 24.10 |
| Cash Ratio | 0.00 | 1.65 | 0.00 |
| Working Capital | ₩7.76 Billion | ₩ 9.87 Billion | ₩ 27.17 Billion |
Celemics Inc - Advanced Valuation Insights
This section examines the relationship between Celemics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.78 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 62.3% |
| Total Assets | ₩29.41 Billion |
| Market Capitalization | $31.75 Million USD |
Valuation Analysis
Below Book Valuation: The market values Celemics Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Celemics Inc's assets grew by 62.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Celemics Inc (2017–2024)
The table below shows the annual total assets of Celemics Inc from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩29.41 Billion | +62.34% |
| 2023-12-31 | ₩18.12 Billion | -18.43% |
| 2022-12-31 | ₩22.21 Billion | -17.42% |
| 2021-12-31 | ₩26.90 Billion | -12.10% |
| 2020-12-31 | ₩30.60 Billion | +325.11% |
| 2019-12-31 | ₩7.20 Billion | -17.89% |
| 2018-12-31 | ₩8.77 Billion | +59.68% |
| 2017-12-31 | ₩5.49 Billion | -- |